Delcath Systems Research and Development Expenses 2010-2024 | DCTH

Delcath Systems research and development expenses from 2010 to 2024. Research and development expenses can be defined as an expense arising from studies and product development processes.

Delcath Systems Research and Development Expenses 2010-2024 | DCTH

Delcath Systems research and development expenses from 2010 to 2024. Research and development expenses can be defined as an expense arising from studies and product development processes.
Related Stocks
Company NameMarket
Cap
Thermo Fisher Scientific (TMO)$212.5B
Intuitive Surgical (ISRG)$180.7B
Alcon (ALC)$45.5B
Edwards Lifesciences (EW)$40B
IQVIA Holdings (IQV)$38.1B
IDEXX Laboratories (IDXX)$33.9B
DexCom (DXCM)$27.2B
Waters (WAT)$23B
STERIS (STE)$22.3B
SONOVA HOLDING (SONVY)$22B
Hologic (HOLX)$19.4B
Fresenius Medical Care AG KGaA (FMS)$11.8B
Sysmex ADR (SSMXY)$11.6B
Globus Medical (GMED)$10.1B
Teleflex (TFX)$9.6B
Penumbra (PEN)$8.8B
Masimo (MASI)$7.8B
Glaukos (GKOS)$7.2B
PROCEPT BioRobotics (PRCT)$5.1B
Integer Holdings (ITGR)$4.2B
Inari Medical (NARI)$2.9B
TransMedics (TMDX)$2.9B
Veracyte (VCYT)$2.7B
LivaNova (LIVN)$2.7B
Nihon Kohden (NHNKY)$2.6B
Elekta AB (EKTAY)$2.3B
Tandem Diabetes Care (TNDM)$2.2B
RxSight (RXST)$1.9B
Integra LifeSciences Holdings (IART)$1.9B
Alphatec Holdings (ATEC)$1.2B